Invivyd Stock Quote IVVD - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.10

Bid

1.00

Ask

1.25

Volume

0.00 Day's Range 0.00

1.05 52 Week Range 5.195

Market Cap

131.247M

Previous Close

1.10

Open

Last Trade

1.1

Last Trade Time

08:02:54

Financial Volume

VWAP

Average Volume (3m)

721,926

Shares Outstanding

119,315,787

Dividend Yield

PE Ratio

-0.66

Earnings Per Share (EPS)

-1.66

Revenue

Net Profit

-198.64M

Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

invivyd.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Invivyd Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IVVD. The last closing price for Invivyd was $1.10. Over the last year, Invivyd shares have traded in a share price range of $ 1.05 to $ 5.195.

Invivyd currently has 119,315,787 shares outstanding. The market capitalization of Invivyd is $131.25 million. Invivyd has a price to earnings ratio (PE ratio) of -0.66.

Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial

Newly outlined pathway provides a practical, expedient, repeatable immunobridging approach to potential emergency use authorization of serial, novel monoclonal antibodies (mAbs) to prevent and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-8.33333333333	1.2	1.63	1.08	2838853	1.12916361	CS
4	-0.69	-38.5474860335	1.79	1.85	1.08	967531	1.20983212	CS
12	-1.9	-63.3333333333	3	3.1393	1.08	721926	1.83883838	CS
26	-2.68	-70.8994708995	3.78	5.195	1.08	775887	3.14834765	CS
52	0.05	4.7619047619	1.05	5.195	1.05	781704	3.15192307	CS
156	-3.6	-76.5957446809	4.7	5.195	0.9802	574320	2.88273277	CS
260	-3.6	-76.5957446809	4.7	5.195	0.9802	574320	2.88273277	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VVPRVivoPower International PLC	$ 3.43 (128.67%)	13.99M
ZCARZoomcar Holdings Inc	$ 0.2185 (59.96%)	42.07M
CBRGChain Bridge I	$ 17.88 (57.26%)	129
DOYUDouYu International Holdings Ltd	$ 16.6998 (32.64%)	945.1k
ENGENGlobal Corp	$ 1.68 (28.24%)	49
SHPWShapeways Holdings Inc	$ 0.339 (-51.98%)	93.34k
TOIIWOncology Institute Inc	$ 0.0185 (-27.45%)	1
RPAYRepay Holdings Corporation	$ 8.08 (-20.86%)	15
NPCENeuropace Inc	$ 5.76 (-20.33%)	192
STISolidion Technology Inc	$ 0.392 (-16.90%)	535.71k
ZCARZoomcar Holdings Inc	$ 0.2185 (59.96%)	42.07M
MAXNMaxeon Solar Technologies Ltd	$ 0.1999 (11.12%)	33.12M
VVPRVivoPower International PLC	$ 3.43 (128.67%)	13.99M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.89 (4.04%)	11.58M
TSLATesla Inc	$ 235.94 (2.02%)	7M